By Business/Source
Currency:CNY
2025/H1
Stock NameRevenueRatio
从事(i)治疗结构性心脏病的介入产品及其他相关医疗产品的研发及(ii)治疗结构性心脏病的介入产品的制造及销售13.43M100.00%
By Product
Currency:CNY
2025/H1
Stock NameRevenueRatio
从事(i)治疗结构性心脏病的介入产品及其他相关医疗产品的研发及(ii)治疗结构性心脏病的介入产品的制造及销售13.43M100.00%
By Country/Region
No Data